Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$136,332
-$28,511 QoQ
Shares Held
19,256
-6.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 164 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Creative Planning holds $1,825,978,859 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
445,706 | $534,593,191 | |
| 2 | JNJ |
Johnson & Johnson
|
1,384,963 | $351,739,052 | |
| 3 | ABBV |
AbbVie Inc.
|
1,126,243 | $283,407,788 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,354,765 | $174,087,302 | |
| 5 | AMGN |
Amgen Inc
|
258,171 | $93,488,882 | |
| 6 | NVS |
Novartis AG
|
546,659 | $85,672,398 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
414,367 | $52,351,126 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
887,032 | $51,110,783 |
All Filings in GRFS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,332 | 19,256 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $164,843 | 20,554 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $193,367 | 20,681 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $163,482 | 16,414 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $129,027 | 14,273 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $105,142 | 14,788 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $107,069 | 14,391 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $153,791 | 17,319 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $86,478 | 13,705 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $98,917 | 14,808 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $199,247 | 17,236 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $183,795 | 20,109 | Shares | Defined | 2023-11-16 | |
| 2023-06-30 | $178,565 | 19,494 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $98,544 | 13,371 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $102,739 | 12,087 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $78,059 | 12,672 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $130,121 | 10,953 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $124,590 | 10,667 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $115,320 | 10,269 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $239,457 | 16,390 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $755,592 | 43,550 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,713,058 | 99,078 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,455,471 | 187,390 | Shares | Sole | 2021-01-29 | |
| No filing history on record for this holder in this stock. | ||||||